IP Library Granted Patent US 8,618,118
Granted Patent B2
US 8,618,118 · App. 13/359,393 · Granted Dec 31, 2013

Remedy for migraine headache

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,618,118
App. No.
13/359,393
Granted
Dec 31, 2013
Kind
B2
Abstract

A medication formulation and method of use for treating migraine having a combination of active ingredients including: nicotine, phenylalanine, tyrosine, and caffeine in an aqueous solution.

Claims (10)

1. A medication formulation for treating migraine comprising an aqueous solution containing active ingredients including an effective amount of: nicotine, tryptophan, phenylalanine, tyrosine and caffeine, wherein the nicotine comprises approximately 0.222 mg.

2. A medication formulation for treating migraine comprising an aqueous solution containing active ingredients including approximately: 0.222 mg nicotine, 40 mg tryptophan, 20 mg phenylalanine, 60 mg tyrosine, and 85 mg caffeine in approximately two liquid ounces of water.

3. The medication formulation of claim 1 wherein the nicotine represents about 0.11% by weight of the active ingredients.

4. The medication formulation of claim 1 , wherein the tryptophan represents between 15% and 30% by weight of the active ingredients.

5. The medication formulation of claim 1 , wherein the phenylalanine represents between 5% and 15% by weight of the active ingredients.

6. The medication formulation of claim 1 , wherein the tyrosine represents between 20% and 30% by weight of the active ingredients.

7. The medication formulation of claim 1 , wherein the caffeine represents between 35% and 50% by weight of the active ingredients.

8. A medication formulation for treating migraine comprising an aqueous solution containing active ingredients including by weight approximately: nicotine 0.1%, tryptophan 18.1%, phenylalanine 9.0%, tyrosine 27.1%, and caffeine 38.4%.

9. The medication formulation of claim 8 further including at least one non-essential amino acid.

10. The medication formulation of claim 9 wherein the non-essential amino acid is at least one of: serine, aspartic acid, and glutamic acid.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2017
From: KNIGHT, JOSEPH R.
To: MICROSTRADA RESEARCH, LLC
Reel/Frame 043056/0792 →
CORRECTED BY AFFIDAVIT REEL/FRAME 033083/0007 Recorded Jul 15, 2015
From: KNIGHT, JOSEPH ROBERT
To: KNIGHT, JOSEPH ROBERT
Reel/Frame 036204/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2015
From: NICO WORLDWIDE, INC.
To: MYCRATINE SOLUTIONS, LLC
Reel/Frame 036032/0495 →
SECURITY INTEREST Recorded Jun 3, 2014
From: NICO WORLDWIDE, INC.
To: DE CSEPEL, DAVID L
Reel/Frame 033083/0074 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2014
From: KNIGHT, JOSEPH R., MR.
To: NICO WORLDWIDE, INC.
Reel/Frame 032306/0330 →